Skip to main content
Lifecare ASA logo

Lifecare ASA — Investor Relations & Filings

Ticker · LIFE ISIN · NO0013355859 LEI · 254900D88MYGZ7JD5P39 OL Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2021-02-15 Report Publication Anno…
Country NO Norway
Listing OL LIFE

About Lifecare ASA

https://lifecare.no/

Lifecare ASA is a clinical-stage medical sensor company specializing in the development of nanotechnology for medical applications. Its core activity involves creating miniaturized, implantable, and long-term nanobiosensors for the continuous monitoring of various body analytes. The company's primary focus is on developing a sensor for correct and continuous glucose monitoring to improve diabetes management. The business model is based on developing and licensing its proprietary sensor technology to facilitate the production and sale of advanced medical devices.

Recent filings

Filing Released Lang Actions
Financial calendar
Report Publication Announcement Classification · 100% confidence The document is titled 'Financial calendar' and lists key future dates for the company, including the release of the 'Half-yearly Report', 'Annual Report', and 'Annual General Meeting'. This document is purely informational regarding the schedule of future corporate events and reports, not the reports themselves. It does not fit the specific definitions for AGM-R, 10-K, ER, or IR. Since it is a general announcement about the schedule of corporate events/filings, it best fits the general regulatory announcement category, which is RNS, as it doesn't map to any other specific announcement type like DIV or DVA.
2021-02-15 English
Lifecare AS - Development Update Q4 2020; Positive financial and technical development.
Earnings Release Classification · 100% confidence The document is titled "Lifecare AS - Development Update Q4 2020; Positive financial and technical development." It provides preliminary financial results (net profit for Q4 2020 and the full year 2020), discusses R&D progress (Sencell, FORGETDIABETES project), and outlines future plans for 2021, including clinical trials and regulatory submissions. This content structure—a summary of operational and financial performance for a specific period (Q4 2020) that is not the full annual report (10-K) and is more detailed than a simple earnings release (ER)—strongly suggests an Interim/Quarterly Report (IR). It is a comprehensive update covering financials and operations for a period shorter than a year. Q4 2020
2021-01-27 English
Lifecare AS (LIFE) – Share sale by close associate to primary insider
Director's Dealing Classification · 98% confidence The document text explicitly details a share sale transaction conducted by a close associate (Islay Venture GmbH, controlled by the CSO) of a primary insider (Prof. Dr. Dr. med Andreas Pfützner) in Lifecare AS. This directly corresponds to the definition of 'Director's Dealing' or insider transaction reporting. The appropriate code is DIRS.
2020-12-16 English
Lifecare AS strengthens its Board of Directors at todays extraordinary general meeting.
AGM Information Classification · 99% confidence The document is titled "Protokoll Fra Ekstraordinær Generalforsamling i Lifecare AS" (Minutes from Extraordinary General Meeting in Lifecare AS). It details the proceedings, shareholder attendance, voting results, and decisions made regarding board appointments and a proposal for a capital increase authorization. This content directly corresponds to the documentation generated following a shareholder meeting, specifically an Extraordinary General Meeting (EGM). The closest matching category is AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting (AGM), and by extension, EGMs. Since it is the official minutes/protocol of the meeting, AGM-R is the most appropriate classification.
2020-11-20 Norwegian
Lifecare AS strengthens its Board of Directors at todays extraordinary general meeting.
Board/Management Information Classification · 98% confidence The document explicitly states that an 'extraordinary general meeting' was held and details the outcome: the strengthening of the Board of Directors by electing new members (Morten Foros Krohnstad, Lutz Heinemann, Bo Petersson). This content directly relates to changes in the company's governing body. Therefore, the most appropriate classification is Board/Management Information (MANG). Although an EGM was held, the focus is on the resulting board composition, not the voting results (DVA) or the minutes themselves (which are mentioned as attached, suggesting this is the announcement, not the formal minutes).
2020-11-20 English
Lifecare presents scientific update at the Diabetes Technology Meeting
Regulatory Filings Classification · 99% confidence The document is a short press release announcing that the company, Lifecare, will present scientific updates regarding its Sencell Glucose Sensor development at the upcoming Diabetes Technology Meeting. It details the topic of the presentation and quotes executives. This is not a formal regulatory filing (like 10-K, IR, ER), nor is it a presentation document itself (IP). It is a general announcement about company activity and scientific progress, which fits best under the general 'Regulatory Filings' (RNS) category as a miscellaneous corporate announcement, or potentially an Investor Presentation (IP) if it were the actual presentation slides, but since it's just an announcement *about* a presentation, RNS is the most appropriate fallback for non-standard corporate news releases that don't fit specific categories like ER, DIV, or MANG.
2020-11-12 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.